Deferoxamine mesylate
NDC 60505-6237, Deferoxamine mesylate, injection, powder, lyophilized, for solution, from Apotex Corp..
- Product NDC
- 60505-6237
- Status
- Listed
- Labeler
- Apotex Corp.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207384
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6237 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEFEROXAMINE MESYLATE2 g/1
Pharmacologic classes
Iron Chelating Activity [MoA]; Iron Chelator [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60505-6237-6 | 60505623706 | 4 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (60505-6237-6) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c99553fb-3fae-b88a-6c2c-efa7520197f9
Use it
Look up 60505-6237 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6237 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60505-6237. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.